Developing new vaccines and therapeutic antibodies
Official title: Vaccines and Therapeutics Technology Core
Funded at Vanderbilt University Medical Center · NIH-10863657 · Data updated 2026-11-12
This study is working on new and quicker ways to make vaccines and treatments for infections, using cutting-edge technology, so that patients can have access to better options for their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project start | August 20, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $5,228,898 |
| NIH project number | 1U19AI181979-01 |
| Project ID | NIH-10863657 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals at risk for infectious diseases or those who may require new therapeutic options.
✕Less likely to help
Patients with conditions unrelated to infectious diseases may not receive direct benefits from this research.
What this research studies
This research focuses on creating a fast-track process for developing next-generation vaccines and therapeutic antibodies. It involves producing various candidate molecules using advanced technologies, including recombinant virus-like particles and RNA lipid nanoparticles. The project aims to provide essential resources and quality control to ensure the effectiveness of these candidates. Patients may benefit from innovative treatments for infectious diseases as a result of this work.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines and therapies for infectious diseases.
How similar studies have gone: Previous research has shown success in developing vaccines and therapeutic antibodies using similar advanced technologies.
Where this research is happening
-
Vanderbilt University Medical Center
Nashville, United States Active
Researchers
- Principal investigator: Carnahan, Robert H — Vanderbilt University Medical Center
- Study coordinator: Carnahan, Robert H
Related research
Other NIH-funded projects on the same topics.
-
Improving healthcare for patients with inherited cancer syndromes using a web-based platform
This study is testing a new online tool called MeTree that helps people understand their risk for inherited cancer by combining their medical records and family health history, making it easier for patients and doctors to get the information they need for better care and support.
-
Stroke prevention with hydroxyurea for children with sickle cell anemia in Nigeria
A multinational, patient-facing study tests whether hydroxyurea can safely prevent first strokes in Nigerian children with sickle cell anemia.
-
Scaling Up Task-Shifted Epilepsy Care for Children in Africa
A study to help children with epilepsy in Africa get diagnosed and receive seizure care through trained community health workers.
-
Enhanced surveillance for new vaccine‑preventable diseases
A Vanderbilt team is tracking how well vaccines work and how diseases like flu, RSV, norovirus, and SARS‑CoV‑2 affect young children over time.
-
Generative AI to create private, fair health data for research
A researcher at Vanderbilt aims to use Generative AI to create synthetic health data that protects patient privacy while helping AI models be fairer and more accurate.
-
ConProject-003: A patient-facing initiative at Vanderbilt for advancing care
A Vanderbilt-led project (ConProject-003) is funded to drive improvements in care for people with a specific health condition through a dedicated program.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.